Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Investing Cash Flow

Net cash used in or generated by investments in assets, acquisitions, and securities.

Organigram Global Inc.NASDAQ: OGI

Investing Cash Flow · Q2 FY2026 · quarter ended Mar 2026

Investing cash flow declines year over year

Q2 FY2026 investing cash flow of CA$1.87M (cash outflow) fell 81.8% year over year, ahead of the -85.5% change in trailing-twelve-month investing cash flow. Sequentially, it fell 59.1% from the prior quarter.

Context

  • Investing cash flow amounted to 31.9% of revenue in FY2025, up 7.6 pp from a year earlier.
  • Investing cash flow increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -81.8% holds above the trailing-twelve-month pace of -85.5%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$1.87M-59.1% QoQ
Last fiscal yearSep 2025
-CA$59.35M+53.1% YoY
LTMMar 2026
-CA$15.83M-85.5% YoY
Investing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-81.8%——
1 year+53.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Investing Cash Flow history

CAD · from the cash flow

Latest · FY2025
(59.35M) CAD
Year-over-year change
-53.1%

Investing Cash Flow vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so investing cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -85.5% is the 6th highest of 8, against a peer median of -52.2%.
  • Investing cash flow amounts to 5.8% of revenue for OGI, versus a peer median of 23.4%.
OGI Competitors
Investing Cash Flow for OGI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HSDTSolana CompanyLTM Mar 2026$421.06M USD—+3284.7%4391.1%
IVAInventiva S.A.FY2025€127.93M EUR-1562.9%—2853.7%
ACBAurora Cannabis Inc.LTM Mar 2026CA$72.62M CAD+379.1%+39.2%23.4%
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 2026$29.62M USD-246.4%-25.1%90.5%
OGIOrganigram Global Inc.LTM Mar 2026CA$15.83M CAD-85.5%—5.8%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$5.39M USD-65.2%-16.1%3.8%
RNACCartesian Therapeutics, Inc.LTM Mar 2026$4.41M USD-52.2%-28.6%248.2%
LFCRLifecore Biomedical, Inc.LTM Mar 2026$3.09M USD——2.3%
ELMDElectromed, Inc.LTM Mar 2026$1.23M USD+532.8%-41.5%1.7%
DERMJourney Medical CorporationLTM Mar 2026$0 USD+100.0%—0.0%
Peer median (excluding OGI) —-52.2%-20.6%23.4%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(24.76M)
Depreciation & Amortization31.03M24.91M24.08M12.08M17.98M
Deferred Income Tax42.21M(88K)(2.66M)0(13.77M)
Stock-Based Compensation3.9M5.13M5.29M7.18M4.22M
Change in Working Capital24.2M(22.88M)12.51M14.96M(2.12M)
Accounts Receivables(6.01M)(24.02M)12.51M(12.06M)(15.29M)
Inventory28.68M(12.22M)000
Accounts Payables2.06M12.15M000
Other Working Capital(542K)1.21M(4.06M)27.02M13.16M
Other Non-Cash Items776K(29M)151.8M15.09M14.16M
Operating Cash Flow(28.59M)(36.21M)(35.8M)3.87M(4.3M)
Capital Expenditures(12.33M)(48.78M)(26.9M)(5.34M)(12.22M)
Acquisitions (Net)(2.54M)(11.06M)00(65.62M)
Purchases of Investments(120.02M)(15M)(7.36M)(29.24M)(1.01M)
Sales of Investments50.85M114.59M36.37M3.52M2.5M
Other Investing Activities(31.08M)4.29M31.46M(8.32M)21.8M
Investing Cash Flow(115.11M)44.03M4.56M(38.77M)(59.35M)
Debt Repayment(116.4M)(1.01M)(64.04K)(786K)(43.08K)
Common Stock Issued284.88M6.34M20K108.56M29.57M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities5.99M6.34M(754.15K)6K(1.29M)
Financing Cash Flow174.46M5.33M(754.15K)107.78M28.24M
Effect of Forex Changes0000(2.57M)
Net Change in Cash30.77M13.15M(68.52M)72.88M(37.98M)
Free Cash Flow(40.92M)(84.99M)(62.7M)(1.47M)(16.52M)

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.